SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950149-00-002025
Filing Date
2000-09-14
Accepted
2000-09-14 00:00:00
Documents
9
Period of Report
2000-09-13
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f65194e8-k.txt 8-K 3532
2 FORM OF NOTE PURCHASE AGREEMENT f65194ex1-1.txt EX-1.1 107290
3 FORM OF INDENTURE f65194ex4-1.txt EX-4.1 249588
4 FORM OF SUPPLEMENTAL INDENTURE f65194ex4-2.txt EX-4.2 264960
5 FORM OF COMMON STOCK PURCHASE WARRANT f65194ex4-3.txt EX-4.3 54564
6 AXYS PHARM. PRESS RELEASE DATED SEPT. 12, 2000 f65194ex20-1.txt EX-20.1 1395
7 DISCOVERY PARTNERS CONSOLIDATED FINANCIAL STMNTS. f65194ex20-2.txt EX-20.2 70436
8 INTERIM FINANCIAL STATEMENTS OF DISCOVERY PARTNERS f65194ex20-3.txt EX-20.3 24720
9 CONSENT OF ERNST & YOUNG, LLP f65194ex23-1.txt EX-23.1 653
  Complete submission text file 0000950149-00-002025.txt   779996
Mailing Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080 6508291000
AXYS PHARMECUETICALS INC (Filer) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22788 | Film No.: 722550
SIC: 2834 Pharmaceutical Preparations